186
Views
8
CrossRef citations to date
0
Altmetric
Review

Tea drinking, diet and ischemic stroke prevention in China: a future perspective

, &
Pages 1447-1454 | Published online: 10 Jan 2014

References

  • Mackay J, Mensah G. Atlas of Heart Disease and Stroke. World Health Organization, United Kingdom (2004).
  • Goldstein LB, Adams R, Alberts MJ et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation113(24), E873–E923 (2006).
  • Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N. Engl. J. Med.333(21), 1392–1400 (1995).
  • Sudlow CL, Warlow CP; International Stroke Incidence Collaboration. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke28(3), 491–499 (1997).
  • Jiang B, Wang WZ, Chen H et al. Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke37(1), 63–68 (2006).
  • Kondo R, Matsumori Y, Kato N et al. [Trends in the incidence of stroke in Yamagata, Japan]. No To Shinkei58(3), 213–218 (2006).
  • Long Y, Lu J, Xu DZ et al. [Analysis on direct economic burden of stroke in the rural population of Hanzhong, Shaanxi Province]. Zhonghua Liu Xing Bing Xue Za Zhi26(7), 494–497 (2005).
  • Kincannon CL, He W, West LA. Demography of aging in China and the United States and the economic well-being of their older populations. J. Cross Cult. Gerontol.20(3), 243–255 (2005).
  • Flaherty JH, Liu ML, Ding L et al. China: the aging giant. J. Am. Geriatr. Soc.55(8), 1295–1300 (2007).
  • Binns CW, Lee AH, Fraser ML. Tea or coffee? A case study on evidence for dietary advice. Public Health Nutr.11(11), 1132–1141 (2008).
  • McKay DL, Blumberg JB. The role of tea in human health: an update. J. Am. Coll. Nutr.21(1), 1–13 (2002).
  • Berliner JA, Navab M, Fogelman AM et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation91(9), 2488–2496 (1995).
  • Garcia JH, Lassen NA, Weiller C et al. Ischemic stroke and incomplete infarction. Stroke27(4), 761–765 (1996).
  • Alexander RW. Hypertension and the pathogenesis of atherosclerosis : oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension25(2), 155–161 (1995).
  • Sander D, Kukla C, Klingelhofer J et al. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation102(13), 1536–1541 (2000).
  • Vita JA. Tea consumption and cardiovascular disease: effects on endothelial function. J. Nutr.133(10), S3293–S3297 (2003).
  • Miura Y, Chiba T, Tomita I et al. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J. Nutr.131(1), 27–32 (2001).
  • Maron DJ, Lu GP, Cai NS et al. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch. Intern. Med.163(12), 1448–1453 (2003).
  • Maeda K, Kuzuya M, Cheng XW et al. Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Atherosclerosis166(1), 23–30 (2003).
  • Yang Y-C, Lu F-H, Wu J-S et al. The protective effect of habitual tea consumption on hypertension. Arch. Intern. Med.164(14), 1534–1540 (2004).
  • Hodgson JM, Devine A, Puddey IB et al. Tea intake is inversely related to blood pressure in older women. J. Nutr.133(9), 2883–2886 (2003).
  • Hodgson JM. Effects of tea and tea flavonoids on endothelial function and blood pressure: a brief review. Clin. Exp. Pharmacol. Physiol.33(9), 838–841 (2006).
  • Koga T, Meydani M. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am. J. Clin. Nutr.73(5), 941–948 (2001).
  • Ahn HY, Hadizadeh KR, Seul C et al. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol. Biol. Cell10(4), 1093–1104 (1999).
  • Duffy SJ, Keaney JF Jr, Holbrook M et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation104(2), 151–156 (2001).
  • Wang CP, Ma SJ, Xu XF et al. The prevalence of household second-hand smoke exposure and its correlated factors in six counties of China. Tob. Control18(2), 121–126 (2009).
  • Wong CM, Ou CQ, Chan KP et al. The effects of air pollution on mortality in socially deprived urban areas in Hong Kong. China Environ. Health Perspect.116(9), 1189–1194 (2008).
  • Sun R, Gu D. Air pollution, economic development of communities, and health status among the elderly in urban China. Am. J. Epidemiol.168(11), 1311–1318 (2008).
  • Qian Z, He Q, Lin HM et al. High temperatures enhanced acute mortality effects of ambient particle pollution in the ‘oven’ city of Wuhan. China Environ. Health Perspect.116(9), 1172–1178 (2008).
  • Lokken PR, Wellenius GA, Coull BA et al. Air pollution and risk of stroke: underestimation of effect due to misclassification of time of event onset. Epidemiology20(1), 137–142 (2009).
  • Lisabeth LD, Escobar JD, Dvonch JT et al. Ambient air pollution and risk for ischemic stroke and transient ischemic attack. Ann. Neurol.64(1), 53–59 (2008).
  • Liang W, Binns CW, Jian L et al. Does the consumption of green tea reduce the risk of lung cancer among smokers? Evid. Based Complement Alternat. Med.4(1), 17–22 (2007).
  • Fraser ML, Mok GS, Lee AH. Green tea and stroke prevention: emerging evidence. Complement Ther. Med.15(1), 46–53 (2007).
  • Liang W, Lee AH, Binns CW et al. Tea consumption and ischemic stroke risk: a case-control study in southern China. Stroke40(7), 2480–2485 (2009).
  • Hirvonen T, Virtamo J, Korhonen P et al. Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke31(10), 2301–2306 (2000).
  • Kuriyama S, Shimazu T, Ohmori K et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA296(10), 1255–1265 (2006).
  • Sato Y, Nakatsuka H, Watanabe T et al. Possible contribution of green tea drinking habits to the prevention of stroke. Tohoku J. Exp. Med.157(4), 337–343 (1989).
  • Yochum L, Kushi LH, Meyer K et al. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am. J. Epidemiol.149(10), 943–949 (1999).
  • Thorvaldsen P, Asplund K, Kuulasmaa K et al. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke26(3), 361–367 (1995).
  • Bamford J, Sandercock P, Dennis M et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project – 1981–1986: 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry53(1), 16–22 (1990).
  • Chen Z, Li Y, Zhao LC et al. [A study on the association between tea consumption and stroke]. Zhonghua Liu Xing Bing Xue Za Zhi25(8), 666–670 (2004).
  • Rothman J, Greenland S. Modern Epidemiology. Lippincott-Raven (1998).
  • Soft Drinks in China. Business Insights Ltd, London, UK (2006).
  • Friedman M, Brandon DL. Nutritional and health benefits of soy proteins. J. Agric. Food Chem.49(3), 1069–1086 (2001).
  • Hasler CM. The cardiovascular effects of soy products. J. Cardiovasc. Nurs.16(4), 50–63 (2002).
  • Anderson JW, Smith BM, Washnock CS. Cardiovascular and renal benefits of dry bean and soybean intake. Am. J. Clin. Nutr.70(3), S464–S474 (1999).
  • Sacks FM, Lichtenstein A, Van Horn L et al. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation113(7), 1034–1044 (2006).
  • Reynolds K, Chin A, Lees KA et al. A meta-analysis of the effect of soy protein supplementation on serum lipids. Am. J. Cardiol.98(5), 633–640 (2006).
  • Weggemans RM, Trautwein EA. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur. J. Clin. Nutr.57(8), 940–946 (2003).
  • Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am. J. Clin. Nutr.81(2), 397–408 (2005).
  • Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med.333(5), 276–282 (1995).
  • Balk E, Chung M, Chew P et al. Effects of soy on health outcomes. Evid. Rep. Technol. Assess. (Summ.)126, 1–8 (2005).
  • Rudel LL, Parks JS, Sawyer JK. Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis. Arterioscler. Thromb. Vasc. Biol.15(12), 2101–2110 (1995).
  • Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler. Thromb.12(8), 911–919 (1992).
  • Mensink RP, Zock PL, Kester AD et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr.77(5), 1146–1155 (2003).
  • He J, Gu D, Wu X et al. Effect of soybean protein on blood pressure: a randomized, controlled trial. Ann. Intern. Med.143(1), 1–9 (2005).
  • Du S, Lu B, Zhai F et al. A new stage of the nutrition transition in China. Public Health Nutr.5(1A), 169–174 (2002).
  • Liang W, Lee AH, Binns CW et al. Soy consumption reduces risk of ischemic stroke: a case-control study in southern China. Neuroepidemiology33(2), 111–116 (2009).
  • Liang W, Lee AH, Binns CW et al. Are soy foods protective against ischemic stroke? Future Neurology2(5), 505–511 (2007).
  • Merchant AT, Anand SS, Kelemen LE et al. Carbohydrate intake and HDL in a multiethnic population. Am. J. Clin. Nutr.85(1), 225–230 (2007).
  • Ma Y, Li Y, Chiriboga DE et al. Association between carbohydrate intake and serum lipids. J. Am. Coll. Nutr.25(2), 155–163 (2006).
  • Villegas R, Liu S, Gao Y-T. et al. Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of Type 2 diabetes mellitus in middle-aged chinese women. Arch. Intern. Med.167(21), 2310–2316 (2007).
  • Gross LS, Li L, Ford ES et al. Increased consumption of refined carbohydrates and the epidemic of Type 2 diabetes in the United States: an ecologic assessment. Am. J. Clin. Nutr.79(5), 774–779 (2004).
  • Liu S. Intake of refined carbohydrates and whole grain foods in relation to risk of Type 2 diabetes mellitus and coronary heart disease. J. Am. Coll. Nutr.21(4), 298–306 (2002).
  • Oh K, Hu FB, Cho E et al. Carbohydrate intake, glycemic index, glycemic load, and dietary fiber in relation to risk of stroke in women. Am. J. Epidemiol.161(2), 161–169 (2005).
  • Kaushik S, Wang JJ, Wong TY et al. Glycemic index, retinal vascular caliber, and stroke mortality. Stroke40(1), 206–212 (2009).
  • Du S, Lu B, Zhai F et al. A new stage of the nutrition transition in China. Public Health Nutr.5(1A), 169–174 (2002).
  • Zhai F, Wang H, Du S et al. Lifespan nutrition and changing socio–economic conditions in China. Asia Pac. J. Clin. Nutr.16(Suppl. 1), 374–382 (2007).
  • World Health Organization. WHO forum on reducing salt intake in populations. World Health Organization, Paris, France (2006).
  • Pearson TA, Blair SN, Daniels SR et al. 2002 AHA guidelines for primary prevention of cardiovascular disease and stroke: update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation106(3), 388–391 (2002).
  • Gu D, Reynolds K, Wu X et al. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension40(6), 920–927 (2002).
  • Appel LJ, Brands MW, Daniels SR et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension47(2), 296–308 (2006).
  • Whelton SP, Chin A, Xin X et al. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann. Intern. Med.136(7), 493–503 (2002).
  • Hambrecht R, Fiehn E, Weigl C et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation98(24), 2709–2715 (1998).
  • Fang XH, Longstreth WT Jr, Li SC et al. longitudinal study of blood pressure and stroke in over 37,000 people in china. Cerebrovasc. Dis.11(3), 225–229 (2001).
  • Roquer J, Segura T, Serena J et al. Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc. Dis.27(Suppl. 1), 25–37 (2009).
  • Evenson KR, Rosamond WD, Cai J et al. Physical activity and ischemic stroke risk. The atherosclerosis risk in communities study. Stroke30(7), 1333–1339 (1999).
  • Hu G, Sarti C, Jousilahti P et al. Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke36(9), 1994–1999 (2005).
  • Sacco RL, Gan R, Boden-Albala B et al. Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke29(2), 380–387 (1998).
  • Krarup LH, Truelsen T, Pedersen A et al. Level of physical activity in the week preceding an ischemic stroke. Cerebrovasc. Dis.24(2–3), 296–300 (2007).
  • Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke34(10), 2475–2481 (2003).
  • Liang W, Lee AH, Binns CW et al. Habitual physical activity reduces risk of ischemic stroke: a case-control study in southern China. Cerebrovasc. Dis.28(5), 454–459 (2009).
  • Freeman DJ, Griffin BA, Murray E et al. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur. J. Clin. Invest.23(10), 630–640 (1993).
  • Lekakis J, Papamichael C, Vemmos C et al. Effects of acute cigarette smoking on endothelium-dependent arterial dilatation in normal subjects. Am. J. Cardiol.81(10), 1225–1228 (1998).
  • Sinha S, Luben RN, Welch A et al. Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population. Eur. J. Cardiovasc. Prev. Rehabil.12(2), 144–150 (2005).
  • Schwartz SW, Carlucci C, Chambless LE et al. Synergism between smoking and vital exhaustion in the risk of ischemic stroke: evidence from the ARIC study. Ann. Epidemiol.14(6), 416–424 (2004).
  • Gorelick PB, Rodin MB, Langenberg P et al. Weekly alcohol consumption, cigarette smoking, and the risk of ischemic stroke: results of a case-control study at three urban medical centers in Chicago, Illinois. Neurology39(3), 339–343 (1989).
  • Wu Y, Liu X, Li X et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation114(21), 2217–2225 (2006).
  • Xu G, Liu X, Wu W et al. Recurrence after ischemic stroke in chinese patients: impact of uncontrolled modifiable risk factors. Cerebrovasc. Dis.23(2–3), 117–120 (2006).
  • Appleby PN, Davey GK, Key TJ, Hypertension and blood pressure among meat eaters, fish eaters, vegetarians and vegans in EPIC-Oxford. Public Health Nutr.5(5), 645–654 (2002).
  • Umesawa M, Iso H, Ishihara J et al. Dietary calcium intake and risks of stroke, its subtypes, and coronary heart disease in japanese: the JPHC study cohort I. Stroke39(9), 2449–2456 (2008).
  • Jorde R, Sundsfjord J, Haug E et al. Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension35(5), 1154–1159 (2000).
  • Jackson KA, Savaiano DA. Lactose maldigestion, calcium intake and osteoporosis in African–, Asian–, and Hispanic–Americans. J. Am. Coll. Nutr.20(2 Suppl.), S198–S207 (2001).
  • Vonk RJ, Priebe MG, Koetse HA et al. Lactose intolerance: analysis of underlying factors. Eur. J. Clin. Invest.33(1), 70–75 (2003).
  • Liang W. Variation in food quality may threaten the validity of epidemiological studies in China. J. Epidemiol. Community Health60(12), 1099 (2006).
  • Wang Z, Mao Y, Gale F. Chinese consumer demand for food safety attributes in milk products. Food Policy33(1), 27–36 (2008).
  • Chan EYY, Griffiths SM, Chan CW. Public-health risks of melamine in milk products. Lancet372(9648), 1444–1445 (2008).
  • Chinese Nutrition Society. The Chinese Dietary Reference Intakes (DRIs). Chinese Nutrition Society, China (2000).
  • He FJ, Nowson CA, MacGregor GA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet367(9507), 320–326 (2006).
  • Chen Z. Launch of the health-care reform plan in China. Lancet373(9672), 1322–1324 (2009).
  • Liang W, Binns CW, Lee AH. Computerised clinical decision support in rural China. Lancet373(9657), 30 (2009).
  • Liang W, Huang R, Lee AH et al. Hospitalizations for incident stroke in Shunde District, Foshan, South China. Neuroepidemiology30(2), 101–104 (2008).
  • Thrift AG, Dewey HM, Macdonell RAL et al. Incidence of the Major Stroke Subtypes: Initial Findings From the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke32(8), 1732–1738 (2001).
  • Jamrozik K, Broadhurst RJ, Lai N et al. Trends in the incidence, severity, and short-term outcome of stroke in perth, Western Australia. Stroke30(10), 2105–2111 (1999).
  • Ellekjaer H, Holmen J, Indredavik B et al. Epidemiology of stroke in innherred, Norway, 1994 to 1996. Incidence and 30-day case-fatality rate. Stroke28(11), 2180–2184 (1997).
  • Kolominsky-Rabas PL, Sarti C, Heuschmann PU et al. A prospective community-based study of stroke in Germany – the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke29(12), 2501–2506 (1998).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.